USANA Health Sciences Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
USANA Health Sciences (USNA) Tops Q1 EPS by 40c, Revenues Beat; Offers FY20 EPS/Revenue Mid-Point Guidance Above Consensus
April 21, 2020 4:18 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q1 EPS of $1.23, $0.40 better than the analyst estimate of $0.83. Revenue for the quarter came in at $266.6 million versus the consensus estimate of $240.68 million.
During this unprecedented period, we extend our gratitude to medical personnel, health officials, government leaders and volunteers around the world who are working tirelessly to respond to the COVID-19 pandemic, said Kevin Guest, Chief Executive Officer. The health, wellness and safety of our employees, Associates and customers around the world remain our top priorities. Accordingly, we have modified our... More
